Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("CpG oligonucleotide")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 25

  • Page / 1
Export

Selection :

  • and

Poly-guanosine strings improve cellular uptake and stimulatory activity of phosphodiester CpG oligonucleotides in human leukocytesBARTZ, Holger; MENDOZA, Yuri; GEBKER, Miriam et al.Vaccine. 2004, Vol 23, Num 2, pp 148-155, issn 0264-410X, 8 p.Article

Immunostimulatory CpG oligonucleotides: Effect on gene expression and utility as vaccine adjuvantsKLINMAN, Dennis M; KLASCHIK, Sven; TOMARU, Koji et al.Vaccine. 2010, Vol 28, Num 8, pp 1919-1923, issn 0264-410X, 5 p.Conference Paper

Recent progress concerning CpG DNA and its use as a vaccine adjuvantSHIROTA, Hidekazu; KLINMAN, Dennis M.Expert review of vaccines. 2014, Vol 13, Num 2, pp 299-312, issn 1476-0584, 14 p.Article

Stable assemblies of cationic bilayer fragments and CpG oligonucleotide with enhanced immunoadjuvant activity in vivoROZENFELD, Julio H. K; SILVA, Sandriana R; RANEIA, Priscila A et al.Journal of controlled release. 2012, Vol 160, Num 2, pp 367-373, issn 0168-3659, 7 p.Article

Delivery by Cationic Gelatin Nanoparticles Strongly Increases the Immunostimulatory Effects of CpG OligonucleotidesZWIOREK, Klaus; BOURQUIN, Carole; BATTIANY, Julia et al.Pharmaceutical research. 2008, Vol 25, Num 3, pp 551-562, issn 0724-8741, 12 p.Article

In vitro immunization can elicit the expansion of diverse repertoire of B cells from peripheral blood mononuclear cellsMATSUMOTO, Shin-Ei; YAMASHITA, Makiko; KATAKURA, Yoshinori et al.Cytotechnology (Dordrecht). 2006, Vol 52, Num 3, pp 227-233, issn 0920-9069, 7 p.Conference Paper

CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaquesKLINMAN, Dennis M; HANG XIE; LITTLE, Stephen F et al.Vaccine. 2004, Vol 22, Num 21-22, pp 2881-2886, issn 0264-410X, 6 p.Article

Polyguanosine motif increases cellular oligonucleotide uptake in the brain cortexZHIREN ZHANG; FAUSER, Uwe; SCHLUESENER, Hermann J et al.Neuroreport (Oxford). 2006, Vol 17, Num 15, pp 1579-1583, issn 0959-4965, 5 p.Article

Toll-like receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotidesMARTIN-ARMAS, Montserrat; SIMON-SANTAMARIA, Jaione; PETTERSEN, Ingvild et al.Journal of hepatology. 2006, Vol 44, Num 5, pp 939-946, issn 0168-8278, 8 p.Article

Potent antigen-specific immune responses stimulated by codelivery of CpG ODN and antigens in degradable microparticlesZHANG, Xue-Qing; DAHLE, Christopher E; BAMAN, Nicki K et al.Journal of immunotherapy (1997). 2007, Vol 30, Num 5, pp 469-478, issn 1524-9557, 10 p.Article

Antitumor efficacy of the novel chemotherapeutic agent coramsine is potentiated by cotreatment with CpG-containing oligodeoxynucleotidesVAN DER MOST, Robbert G; HIMBECK, Robyn; AARONS, Simon et al.Journal of immunotherapy (1997). 2006, Vol 29, Num 2, pp 134-142, issn 1524-9557, 9 p.Article

Significant growth inhibition of orthotopic pancreatic ductal adenocarcinoma by CpG oligonucleotides in immunodeficient miceTEPEL, J; DAGVADORJ, O; KAPISCHKE, M et al.International journal of colorectal disease (Print). 2006, Vol 21, Num 4, pp 365-372, issn 0179-1958, 8 p.Article

Hierarchical recognition of CpG motifs expressed by immunostimulatory oligodeoxynucleotidesKLINMAN, D. M; CURRIE, D.Clinical and experimental immunology (Print). 2003, Vol 133, Num 2, pp 227-232, issn 0009-9104, 6 p.Article

CpG oligonucleotides induce strong humoral but only weak CD4+ T cell responses to protein antigens in rhesus macaques in vivoHARTMANN, Gunther; MARSCHNER, Anja; STEINMAN, Ralph M et al.Vaccine. 2005, Vol 23, Num 25, pp 3310-3317, issn 0264-410X, 8 p.Article

Immunostimulatory CpG oligonucleotides enhance the immune response of anti-idiotype vaccine that mimics carcinoembryonic antigenRATHINDRA NATH BARAL; SAHA, Asim; CHATTERJEE, Sunil K et al.Cancer immunology and immunotherapy. 2003, Vol 52, Num 5, pp 317-327, issn 0340-7004, 11 p.Article

Combination immunotherapy with a CpG oligonucleotide (1018 ISS) and rituximab in patients with non-Hodgkin lymphoma: increased interferon-α/β-inducible gene expression, without significant toxicityFRIEDBERG, Jonathan W; KIM, Helen; MCCAULEY, Mary et al.Blood. 2005, Vol 105, Num 2, pp 489-495, issn 0006-4971, 7 p.Article

Specificity and immunochemical properties of anti-DNA antibodies induced in normal mice by immunization with mammalian DNA with a CpG oligonucleotide as adjuvantTRAN, Trinh T; REICH, Charles F; ALAM, Munir et al.Clinical immunology (Orlando, Fla. Print). 2003, Vol 109, Num 3, pp 278-287, issn 1521-6616, 10 p.Article

Use of CpG oligonucleotides in treatment of asthma and allergic diseaseFONSECA, David E; KLINE, Joel N.Advanced drug delivery reviews. 2009, Vol 61, Num 3, pp 256-262, issn 0169-409X, 7 p.Article

Development of a Murine model to dissect the CpG-oligonucleotide-enhancement of the killing of human B Cells by rituximabBUHE, Virginie; PERS, Jacques-Olivier; MARIANOWSKI, Rémi et al.Journal of autoimmunity (Print). 2010, Vol 34, Num 2, pp 136-144, issn 0896-8411, 9 p.Article

Polarisation of a T-helper cell immune response by activation of dendritic cells with CpG-containing oligonucleotides: a potential therapeutic regime for bladder cancer immunotherapyATKINS, H; DAVIES, B. R; KIRBY, J. A et al.British journal of cancer. 2003, Vol 89, Num 12, pp 2312-2319, issn 0007-0920, 8 p.Article

Novel immunomodulatory oligonucleotides prevent development of allergic airway inflammation and airway hyperresponsiveness in asthmaAGRAWAL, Devendra K; EDWAN, Jehad; KANDIMALLA, Ekambar R et al.International immunopharmacology. 2004, Vol 4, Num 1, pp 127-138, issn 1567-5769, 12 p.Article

CpG oligonucleotide therapy cures subcutaneous and orthotopic tumors and evokes protective immunity in murine bladder cancerNINALGA, Christina; LOSKOG, Angelica; KLEVENFELDT, Magdalena et al.Journal of immunotherapy (1997). 2005, Vol 28, Num 1, pp 20-27, issn 1524-9557, 8 p.Article

CpG Oligonucleotide and Interleukin 2 stimulation enables higher cytogenetic abnormality detection rates than 12-o-tetradecanolyphorbol-13-acetate in Asian patients with B-cell chronic lymphocytic leukemia (B-CLL)FIONA PUI SAN LIAW; LAI CHING LAU; ALVIN SOON TIONG LIM et al.International journal of hematology. 2014, Vol 100, Num 6, pp 545-553, issn 0925-5710, 9 p.Article

Immunotherapy with dendritic cells and CpG oligonucleotides can be combined with chemotherapy without loss of efficacy in a mouse model of colon cancerBOURQUIN, Carole; SCHREIBER, Susanne; BECK, Sebastian et al.International journal of cancer. 2006, Vol 118, Num 11, pp 2790-2795, issn 0020-7136, 6 p.Article

Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphomaFRIEDBERG, Jonathan W; KELLY, Jennifer L; RICH, Lynn et al.British journal of haematology. 2009, Vol 146, Num 3, pp 282-291, issn 0007-1048, 10 p.Article

  • Page / 1